We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Samuel Asirvatham

Samuel J Asirvatham MD, FACC, FHRS

Consultant, Division of Cardiovascular Diseases and Internal Medicine, Division of Pediatric Cardiology, Professor of Medicine and Pediatrics Mayo Clinic College of Medicine, Program Director EP Fellowship Program, Director of Strategic Collaborations Center for Innovation, Mayo Clinic, Rochester, Minnesota

Dr. Asirvatham is presently Professor of Medicine, Professor of Pediatrics, in the Department of Medicine and a Consultant in Cardiac Electrophysiology in the Department of Pediatric Cardiology, Division of Pediatric and Adolescent Medicine. He is also the Program Director for the Clinical Cardiac Electrophysiology Training Program at Mayo Clinic and Director of Strategic Collaborations with the Center of Innovation at Mayo Clinic, Rochester, MN.

These positions allow him to pursue his clinical interests (including radiofrequency ablation of ventricular tachycardia and atrial fibrillation and implantation of newer defibrillators and cardiac resynchronization devices, particularly in patients with congenital heart disease) and research interests (including development of a percutaneous epicardial system to close the left atrial appendage, development of a novel circuit to prevent coagulum formation during radiofrequency ablation procedures and specifically designed and created tools to allow electrophysiology mapping and ablation through the veins of the central nervous system to treat seizures and other central nervous system disorders).

Disclosures

Honoraria/Consulting (none significant):

Abiomed, Atricure, Biotronik, Biosense Webster, Boston Scientific, Medtronic, Medtelligence, St. Jude, Sanofi-Aventis, Wolters Kluwer, Elsevier, Zoll        

Co-patent holder – may receive future royalties from:

Aegis: Appendage ligation

Access Point Technologies: Atrial fibrillation ablation and coagulum reduction during ablation

Nevro: Use of nerve signal modulation to treat central, autonomic, and peripheral nervous system disorders, including pain

Sanovas: Lung ablation

Sorin Medical: Tricuspid valve project